Free Trial

Ambu A/S (OTCMKTS:AMBBY) Sets New 12-Month Low - Here's What Happened

Ambu A/S logo with Medical background

Ambu A/S (OTCMKTS:AMBBY - Get Free Report)'s share price reached a new 52-week low during mid-day trading on Wednesday . The stock traded as low as $14.18 and last traded at $14.18, with a volume of 125 shares. The stock had previously closed at $14.59.

Ambu A/S Stock Performance

The company has a current ratio of 2.49, a quick ratio of 1.47 and a debt-to-equity ratio of 0.09. The company has a market cap of $3.33 billion and a P/E ratio of 118.17. The business's 50 day simple moving average is $17.04 and its 200 day simple moving average is $18.78.

Ambu A/S Announces Dividend

The company also recently disclosed a dividend, which will be paid on Monday, December 23rd. Stockholders of record on Friday, December 6th will be given a dividend of $0.0557 per share. The ex-dividend date of this dividend is Friday, December 6th. Ambu A/S's payout ratio is 16.67%.

About Ambu A/S

(Get Free Report)

Ambu A/S develops, produces, and sells medical devices to hospitals, clinics, and rescue services worldwide. The company offers anaesthesia, and patient monitoring and diagnostics products. The company also offers endoscopy products, such as bronchoscopes, rhinolaryngoscopes, duodenoscopes, cystoscopes, and display units; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should you invest $1,000 in Ambu A/S right now?

Before you consider Ambu A/S, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ambu A/S wasn't on the list.

While Ambu A/S currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Elon Musk's Next Move Cover

Wondering when you'll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to learn when Elon Musk will let these companies finally IPO.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

From Landfills to Profits: Opal Fuels CEO Shares How the Company Turns Trash into Cash
The Real Reason Tesla Stock Is Soaring – and Why Tech Expert Says It Won’t Stop
Best ETFs for 2025: Growth, Stability, and AI-Driven Investing

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines